PASSERI DANIEL R, CEO of CURIS INC(NasdaqGM: CRIS | Quote | Chart | News | PowerRating) bought 20,000 shares of CRIS from the open market on 2008-08-07. The stock was up 4.64% after the InsiderCow.com report.
Trade amount: 20,000 Shares
Trade type: Open Market Buy
Price Range: $1.55
Transaction details can be found at http://www.insidercow.com/history/company.jsp?company=CRIS. You can also get real-time alert on any insider trading information from www.insidercow.com, one step before everybody else.
About InsiderCow.com
InsiderCow.com is a leading real-time insider trading information provider. InsiderCow.com is the online division of InsiderCow, a privately-owned company specialized in insider trading information. InsiderCow uses its proprietary software to gather and analyze information provided by the U.S. Securities and Exchange Commission, in real-time. For more information about InsiderCow.com, visit www.insidercow.com.
About CRIS
Curis, Inc., a drug discovery and development company, focuses on developing medicines primarily in the field of cancer. The company's development stage products for the treatment of cancer includes GDC-0449, a Phase I expansion cohort; small molecule and antibody, a preclinical stage product; and CUDC-101.
CONTACT: InsiderCow.com e-mail: support@insidercow.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index